Login / Signup

Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future.

Brian B GodmanAbiodun EgwuenuEvelyn WesangulaNatalie SchellackAubrey Chichonyi KalungiaCelda TiroyakgosiJoyce KgatlwaneJulius Chacha MwitaOkwen PatrickLoveline Lum NibaAdefolarin A AmuRacheal Tomilola OguntadeMobolaji Eniola AlabiNondumiso B Q NcubeIsrael Abebrese SefahJoseph AcolatseRobert IncoomAnastasia Nkatha GuantaiMargaret OlukaSylvia OpangaIbrahim ChikoweFelix KhuluzaFrancis K ChiumiaCollins Edward JanaFrancis KalemeeraEster HangoJoseph Olusesan FadareOlanyika O OgunleyeBernard E EbrukeJohanna Catharina MeyerAmos MasseleOliver Ombeva MalandeDan KibuuleOtridah KaponaTrust ZaranyikaMutsa Bwakura-DangarembiziTapiwanashe KujingaZikria SaleemAmanj Baker KurdiMoyad ShahwanAmmar Abdulrahman JairounJanney WaleAdrian J Brink
Published in: Expert opinion on drug safety (2022)
All surveyed sub-Saharan African countries have developed their NAPs; however, there is variable implementation. Countries including Botswana and Namibia are yet to officially launch their NAPs with Eswatini only recently launching its NAP. Cameroon is further ahead with its NAP than these countries; though there are concerns with implementation. South Africa appears to have made the greatest strides with implementing its NAP including regular monitoring of activities and instigation of antimicrobial stewardship programs. Key challenges remain across Africa. These include available personnel, expertise, capacity, and resources to undertake agreed NAP activities including active surveillance, lack of focal points to drive NAPs, and competing demands and priorities including among donors. These challenges are being addressed, with further co-ordinated efforts needed to reduce AMR.
Keyphrases
  • antimicrobial resistance
  • quality improvement
  • south africa
  • primary care
  • healthcare
  • public health